U.S. market Closed. Opens in 1 day 7 hours 10 minutes

SBFM | Sunshine Biopharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-07-312007-07-31
Revenue24.09M4.35M228.43K71.41K21.12K447.20KN/AN/A1.71KN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue15.75M2.65M117.83K25.85K11.05K391.08K6.63K60.73K384.58K263.33K475.00K250.00KN/AN/AN/AN/AN/A
Gross Profit8.34M1.70M110.60K45.56K10.07K56.12K-6.63K-60.73K-382.87K-263.33K-475.00K-250.00KN/AN/AN/AN/AN/A
Operating Expenses13.12M10.37M2.55M622.44K651.71K1.22M857.19K993.11K781.99K1.76M1.94M706.68K556.20K537.38K20.0026.08K13.12K
Selling, General & Admin10.83M9.48M1.87M547.42K622.73K1.21M850.56K899.58K769.08K1.43M1.80M704.85K413.55K537.38K20.0026.08K13.12K
Research & Development1.86M811.86K672.21K60.95K15.20K12.80KN/A32.79K8.66K327.00K137.40K1.83K142.65KN/AN/AN/AN/A
Other Operating Expenses438.88K80.40K12.74K14.07K13.77K-871.73K-76.93K60.73K4.25KN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-4.79M-8.67M-2.44M-576.87K-641.64K-1.17M-857.19K-993.11K-780.28K-1.76M-1.94M-706.68K-556.20K-537.38K-15.65K-26.08K-13.12K
Other Expenses / Income674.42K489.61K-10.00M-2.21M-436.42K-989.62K-183.05K-2.50M-872.63K-179.10K-555.41K-1.27KN/AN/A-1.19MN/AN/A
Before Tax Income-4.11M-26.51M-12.44M-2.78M-1.08M-2.16M-1.04M-3.50M-1.65M-1.93M-2.49M-707.95KN/A-537.38KN/AN/AN/A
Income Tax Expenses395.17K233.30K328.82K-1.89M383.39K-41.53K1.29K2.47M565.42K-1.75M548.95K-703.39K556.20KN/AN/A31.11K13.12K
Net Income-4.51M-26.74M-12.77M-897.68K-1.46M-2.16M-1.04M-3.50M-1.65M-1.93M-2.49M-707.95K-556.20K-537.38KN/A-31.11K-13.12K
Interest Expenses137.31K39.41K328.82K168.10K115.90K159.42K104.83K34.73K307.21K179.10K6.46K1.27KN/AN/AN/A5.03K-13.12K
Basic Shares Outstanding12.16K7.59K1.31K866.001.76K15.23K43.63K21.24K1.53K3.68K3.01K2.57K2.44K1.53K23.47K468.00468.00
Diluted Shares Outstanding12.16K7.59K1.31K866.001.76K15.23K43.63K21.24K1.53K3.68K3.01K2.57K2.44K1.53K23.47K468.00468.00
EBITDA-3.82M-26.45M-12.09M-2.60M-948.38K-1.95M-928.78K-932.38K-1.34M-9.77K-555.03K-4.56K-556.20K-537.38K-1.20M-26.08K-13.12K
EBITDA Margin-15.87%-608.58%-5,294.88%-3,643.64%-4,490.22%-434.96%0.00%0.00%-78,539.23%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-3.97M-26.47M-12.11M-2.62M-962.15K-2.04M-934.12K-993.11K-780.28K-3.50M-1.94M-1.41MN/A-537.38KN/A5.03K-13.12K
EBIT Margin-16.49%-609.16%-5,300.46%-3,663.33%-4,555.43%-455.78%0.00%0.00%-45,683.67%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-07-312007-07-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙